Fighting for victims of Drug-Coated Stents
Email this page to a friend Print this page

WWW.FINZFIRM.COM
1-888-FINZFIRM
1-888-346-9347
Finz & Finz, P.C.
Attorneys And Counselors At Law

New York Defective Medical Product Lawyer

Recent findings raise concern for New York drug-coated stents

For people with heart conditions, drug-coated stents - tiny coils which are placed in your artery and slowly release medicine, were intended to make sure the artery did not shut down. Over six million people around the world have received stents as they now account for almost 90 percent of implants. However, a recent Swiss study reports that patients with the drug-coated stents implanted in their arteries were found to have a significantly higher risk of sudden death than those who received drug-free metal stents. The risk is associated with patients who have discontinued the drug Plavix, a blood thinner often prescribed to patients who undergo a heart procedure called an angioplasty. Has your loved one been injured or killed due to the implant of a New York drug-coated stent. An defective medical product lawyer at Finz & Finz, P.C. can help assist you in your legal suit for compensation. Contact a New York New York Defective Medical Product Lawyer today!

Drug-coated stents now under FDA scrutiny as a defective product

There has been growing concern about the long-term safety of drug-coated stents. In addition to the recently released Swiss study where it was found that patients were twice as likely to be at risk for serious blood clots if they discontinued their Plavix medication, two additional studies in the United States and Netherlands found that deaths and heart attacks were higher with coated stents after three years. According to new studies, it was found that defective drug-coated stents product may hinder the heart's natural ability to form tiny collateral blood vessels that can salvage heart muscle by rerouting the blood supply.

If you or a loved one been injured or killed due to the implant of a drug-coated stent, our New York Defective Medical Product Lawyer can help assist you in your legal suit for compensation.

In October 2006, the American College of Cardiology's online medical journal reported that drug-coated stent use results in an estimated 2,160 excess deaths in the United States each year.

While some New York doctors have prescribed the long-term use of Plavix, it is still under further study whether or not there are negative long-term effects from using the drug for extended periods of time. As a result, the U.S. Food and Drug Administration conducted a critical advisory panel meeting in December 2006 to consider the safety of defective drug-eluting stents. An attorney can inform you about your safety if suffering injuries from a defective drug-coated stent. Contact a Defective Medical Product Lawyer today!

Have you, a friend or a loved one been exposed to the risks associated to a defective product in New York?

If you or a family member have had a drug-coated stent implantation and have suffered from a blood clot or heart-related adverse affect, please contact a New York Defective Medical Product Lawyer of Finz & Finz, P.C. today at (888) FINZ-FIRM today or fill out the the Free Case Evaluation form on the right.

>> Back to Top

Drug-Coated Stent News

Boston Scientific expects continued stent recovery

Jun 16, 2008 | Associated Press | CNN News
Boston Scientific Corp. expects the drug-coated stent market to continue recovering, as it works to place its line of Taxus products at the front of a crowded, competitive field...
FULL STORY

Study finds new generation of drug-coated stent benefits heart patients

May 16, 2008 | Associated Press | Canadian Online Pharmacy
A two-year study comparing a new generation drug-coated stent, XIENCE, with a currently used drug eluting stent, TAXUS, has found that the XIENCE stent had superior benefits in more than 1,000 patients...
FULL STORY

Drug-Coated Stent Fit for the Long Haul?

May 5, 2008 | Daniel J. DeNoon | WedMD Medical News
The new Xience stent beat the popular Taxus stent in a one-year trial, but experts disagree on whether stent science is moving too fast...
FULL STORY
More Drug-Coated Stent News...
[1] 2 3 4 5 6 7 8

(required) Denotes required field


Title


(required) First Name


(required) Last Name


(required) Email Address


(required) Phone Number


Address


City


(required) State


Zip Code


Best Way/Time to Contact You


Injured Person's Name


Injured Person's Date of Birth
(mm/dd/yyyy)

Date of Incident
(mm/dd/yyyy)

Type of Incident


Please Describe the Incident


Please sign me up for the Finz & Finz, P.C. Newsletter


I agree to the Finz & Finz, P.C. Terms of Use